1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 1: Demographic characteristics according to iCL status
iCL-Negative Subgroup (n = 16) iCL-Positive Subgroup (n = 55) P Value No. (%) women 10/16 (63) 33/55 (43) .86a Median age at MR imaging (yr) (25th, 75th percentile) 27 (25–36.5) 40 (32–53) .003b Median disease duration (mo) (25th, 75th percentile) 15 (9–34.5) 77 (26–171) <.001b Median EDSS score (25th, 75th percentile) 2 (1.25–3) 3.5 (2–4.5) .02b MS phenotype (No.) (%) Relapsing-remitting 15 (94) 39 (71) Secondary-progressive 0 12 (22) Primary-progressive 1 (6) 4 (7) .11a